This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Progenics Pharmaceuticals Inc (PGNX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 65.86M 58.84M 70.10M 47.92M
Receivables 2.88M 6.94M 1.52M 2.28M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 1.94M 1.69M 919.00K 1.80M
Total Current Assets 70.68M 67.47M 72.54M 52.00M
Property, Plant & Equipment, Gross 14.53M 15.67M 26.10M 30.06M
Accumulated Depreciation & Depletion 12.12M 12.27M 22.06M 24.18M
Property, Plant & Equipment, Net 2.41M 3.40M 4.04M 5.88M
Intangibles 31.38M 0.00 0.00 0.00
Other Non-Current Assets 2.36M 3.39M 3.53M 4.86M
Total Non-Current Assets 43.86M 8.84M 7.57M 10.74M
Liabilities & Shareholder Equity
Total Assets 114.54M 76.31M 80.11M 62.74M
Accounts Payable 793.00K 229.00K 309.00K 658.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 431.00K 115.00K 115.00K 1.29M
Total Current Liabilities 6.63M 8.66M 6.65M 9.80M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 12.32M 0.00 0.00 0.00
Other Non-Current Liabilities 16.61M 1.08M 1.66M 1.64M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 28.94M 1.08M 1.66M 1.64M
Total Liabilities 35.56M 9.74M 8.31M 11.43M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 78.98M 66.57M 71.80M 51.31M
Common Par 79.00K 61.00K 44.00K 43.00K
Additional Paid In Capital 548.51M 493.61M 463.44M 453.35M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -466.68M -424.10M -388.67M -399.06M
Treasury Stock -2.74M -2.74M -2.74M -2.74M
Other Equity Adjustments -192.00K -260.00K -268.00K -292.00K
Total Capitalization 78.98M 66.57M 71.80M 51.31M
Total Equity 78.98M 66.57M 71.80M 51.31M
Total Liabilities & Stock Equity 114.54M 76.31M 80.11M 62.74M
Total Common Shares Outstanding 60.83M 46.57M 33.85M 33.13M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 200.00K 200.00K 200.00K 200.00K
Basic Weighted Shares Outstanding 55.80M 34.75M 33.38M 32.59M
Diluted Weighted Shares Outstanding 55.80M 34.75M 33.49M 32.59M
Number of Employees 69 76 105 159
Number of Part-Time Employees 0 0 0 0

PGNX Progenics Pharmaceuticals Inc

Analysts Ratings for PGNX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 2 2 2 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

PGNX Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs